Key Takeaways
- • Even Healthcare, a Bengaluru-based subscription-based healthcare provider, is raising Rs 208.24 crore ($22 million) in Series B funding led by Khosla Ventures, valuing the company at approximately $300 million.
- • Khosla Ventures is leading the round as an existing investor, demonstrating continued confidence in Even Healthcare's business model and growth trajectory in the digital health sector.
- • Even Healthcare operates a membership-based healthcare model, positioning itself as a recurring revenue healthcare provider in India's growing digital health market.
- • The funding round includes participation from additional investors including 8VC and other US-based institutional backers, indicating strong international investor interest in the Indian healthtech space.
- • This Series B round follows the company's prior $30 million Series A led by Khosla Ventures, reflecting sequential growth in capital raises and valuation milestones for the health tech platform.
Summary
Even Healthcare, a Bengaluru-headquartered digital health startup, is securing Rs 208.24 crore ($22 million) in Series B funding in a round led by existing investor Khosla Ventures. The financing values the company at approximately $300 million, according to multiple sources covering the transaction. The round represents a significant capital injection for the subscription-based healthcare provider as it expands its membership-driven healthcare model across India's growing digital health sector.
Khosla Ventures' continued participation as the lead investor underscores the venture capital firm's conviction in Even Healthcare's business fundamentals and market opportunity. The Series B round also draws participation from 8VC and additional US-based institutional investors, signaling robust international appetite for Indian healthtech platforms. This diversification of investor participation across geographies reflects the maturing perception of India's digital health market among global capital allocators.
The funding milestone marks sequential progression for Even Healthcare, which previously raised $30 million in its Series A round led by the same investor. The membership-based healthcare model—which generates recurring revenue through subscription fees—differentiates Even Healthcare from traditional episodic care providers and aligns with investor preferences for predictable, recurring revenue streams in healthcare technology. The valuation progression from prior rounds to the current $300 million post-money valuation demonstrates investor confidence in the company's unit economics and market expansion potential.
The investment comes as India's digital health sector continues attracting significant institutional capital, driven by rising healthcare costs, expanding internet penetration, and increasing consumer adoption of subscription-based healthcare services. Even Healthcare's ability to secure funding at increasing valuations reflects both company-specific execution and favorable sector dynamics in the broader Indian healthtech ecosystem.
Khosla Ventures' continued participation as the lead investor underscores the venture capital firm's conviction in Even Healthcare's business fundamentals and market opportunity. The Series B round also draws participation from 8VC and additional US-based institutional investors, signaling robust international appetite for Indian healthtech platforms. This diversification of investor participation across geographies reflects the maturing perception of India's digital health market among global capital allocators.
The funding milestone marks sequential progression for Even Healthcare, which previously raised $30 million in its Series A round led by the same investor. The membership-based healthcare model—which generates recurring revenue through subscription fees—differentiates Even Healthcare from traditional episodic care providers and aligns with investor preferences for predictable, recurring revenue streams in healthcare technology. The valuation progression from prior rounds to the current $300 million post-money valuation demonstrates investor confidence in the company's unit economics and market expansion potential.
The investment comes as India's digital health sector continues attracting significant institutional capital, driven by rising healthcare costs, expanding internet penetration, and increasing consumer adoption of subscription-based healthcare services. Even Healthcare's ability to secure funding at increasing valuations reflects both company-specific execution and favorable sector dynamics in the broader Indian healthtech ecosystem.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.